Skip to main content

Published locations for FDA approves neratinib for extended adjuvant treatment of HER2+ breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves neratinib for extended adjuvant treatment of HER2+ breast cancer

User login

  • Reset your password
  • /content/fda-approves-neratinib-extended-adjuvant-treatment-her2-breast-cancer
  • /obgynnews/article/142772/breast-cancer/fda-approves-neratinib-extended-adjuvant-treatment-her2
  • /oncologypractice/article/142772/breast-cancer/fda-approves-neratinib-extended-adjuvant-treatment
  • /obgyn/article/142772/breast-cancer/fda-approves-neratinib-extended-adjuvant-treatment-her2-breast
  • /hematology-oncology/article/142772/breast-cancer/fda-approves-neratinib-extended-adjuvant-treatment
  • /breast-cancer-icymi/article/142772/breast-cancer/fda-approves-neratinib-extended-adjuvant-treatment